These comments are made for the purpose of discussion and should NOT be used as
recommendations for or against therapies or other treatments. An individual patient is
always advised to consult their own physician.
Betapace General Information [posted
11/24/98]
Question: I would like some information on the medication called Betapace. My
mother was recently put on this drug. I'd like to know the long and short term side
effects, pros, cons, and any other important information. Thank you.
Answer: Betapace is an antiarrthymic drug possessing both Class II and Class III activity. Like most of these drugs the benefits/risks depend a great deal on the type and severity of the arrthymia. Side effects of Betapace are fatigue, nausea, slow pulse and there do not appear to be any different long term side effects. Using these drugs is a very individual issue.
Betapace
Question: My grandmother was recently put on Betapace to control arrhythmia, and
she has become incredibly disoriented and confused since taking it. Is this a typical side
effect? My grandmother is 80.5 years old and has never had any signs of memory
loss/Alzheimers previously. Her confusion is VERY strong and she dreams things and
believes they happened. She also doesn't know what day/time it is, etc. Needless to say,
I'm concerned. On Monday she is having about 12" of her intestine removed due to an
ulcerated polyp.
Answer: Betapace(sotalol) is a drug used to treat arrhythmias. It has both Class
II(beta adrenergic blocking) and Class III(cardiac action potential) activity. About 2% of
patients experience a change in mood or mental status while on this drug. About the only
way you will find out if it is the drug or some other problem is to stop the drug. This
should be done post-operatively after her colon surgery when she can be monitored to
ensure that she does not develop severe arrhtymias. If her confusion persists past 2 days
it probably is not the drug.
![]()
Back to Drug InfoNet Home Page.
Back to Medication/Pharmaceutical main page.
Send your impressions, comments, thoughts, etc. to [email protected]
� 1996-97 DRUG INFONET, Inc. All rights reserved.
Last modified August 4, 1997